Celularity and Versea Ophthalmics to commercialize ophthalmic allografts
Celularity - 27-Jul-2023Innovative BIOVANCE single- and three-layer products for ocular surface disease treatment & surgical support
Join the club for FREE to access the whole archive and other member benefits.
Surgeon, biomedical scientist and serial entrepreneur in biomedicine and aerospace
Bob Hariri is a surgeon, biomedical scientist and highly successful serial entrepreneur in two technology sectors: biomedicine and aerospace. The Chairman, Founder, Chief Scientific Officer, and former Chief Executive Officer of Celgene Cellular Therapeutics, one of the world’s largest human cellular therapeutics companies, Dr. Hariri has pioneered the use of stem cells to treat a range of life threatening diseases and has made transformative contributions in the field of tissue engineering.
His activities and experience includes academic neurosurgeon at Cornell, businessman, military surgeon and aviator and aerospace innovator. Dr. Hariri has over 90 issued and pending patents, has authored over 100 published chapters, articles and abstracts and is most recognized for his discovery of pluripotent stem cells from the placenta and as a member of the team which discovered the physiological activities of TNF (tumor necrosis factor).
See also: Celularity - Cell therapeutics company
Details last updated 11-Jan-2020
29-Jul-2021
Dr. Robert Hariri speaks about advances in immunotherapy and regenerative medicine in live AMA with Sergey Young
Innovative BIOVANCE single- and three-layer products for ocular surface disease treatment & surgical support
May cause serious adverse effects if stem cells over attack normal lung cells
Preliminary results from Phase 1 trial look promising
Celularity is a spinout from Celgene, a global biopharmaceutical company. Hopes to use stem cell...
Practice of medicine needs to become the science of medicine Regenerative and Rejuvenative Medic...